Wastewater testing shows sustained MDMA consumption in 2025 with estimated street value of 174.52m
Psychedelic assisted therapy as a last resort treatment is included as part of a funding package for veterans to prevent suicides
Legal access to psychedelic medicine, including psilocybin (magic mushrooms) and MDMA, for treating mental health disorders like PTSD and TRD, is now permitted in Australia. Access remains limited, requiring patients to navigate a complex and costly programs for around $20,000.
Australia remains ahead in legalising psychedelic-assisted therapy, as the FDA rejects Lykos’ MDMA for PTSD treatment.
Three patients are the first in NSW to receive MDMA as part of psychedelic-assisted therapy. The lead director of the program, Professor Ranil Gunewardene, is the only authorised prescriber in the state.
Free, voluntary and confidential pill testing for Schoolies, and what to expect from the service.